
Opening of Abstract Submission:
January 19, 2009
Deadline for Abstract Submission:
June 8, 2009
Reviewing of abstracts:
June 15-26, 2009
Deadline for late breaking Abstract Submission:
July 17, 2009
The reviewers will judge the abstracts according to the relevance to GASTRO 2009, standard of English, objectivity of statement, description of what was done, suitability of methods in relation to aims, conclusions confirmed by objective results, ethics, scientific value, potential clinical value, originality of work and overall impression.
For detailed information please use one of the following links:
Travel Grants to GASTRO 2009 UEGW/WCOG, London
Travel Grants to GASTRO 2009 UEGW/WCOG, London for Basic scientists
| 1 | OESOPHAGEAL, GASTRIC AND DUODENAL DISORDERS |
| 1.1 | Cell/molecular biology/pathology |
| 1.2 | Dyspepsia |
| 1.3 | Barrett's oesophagus |
| 1.4 | Reflux disease, epidemiology |
| 1.5 | Reflux disease, pathogenesis |
| 1.6 | Reflux disease, diagnosis |
| 1.7 | Reflux disease, treatment |
| 1.8 | Reflux disease, complications |
| 1.9 | Oesophageal malignant disease |
| 1.10 | Other oesophageal disorders |
| 1.11 | Acid peptic disease (includes NSAIDS, but NOT H.pylori), epidemiology |
| 1.12 | Acid peptic disease (includes NSAIDS, but NOT H.pylori), pathogenesis |
| 1.13 | Acid peptic disease (includes NSAIDS, but NOT H.pylori), diagnosis and treatment |
| 1.14 | Gastroduodenal malignancies |
| 2 | H. PYLORI |
| 2.1 | Epidemiology/natural history |
| 2.2 | Pathogenesis: microbial factors |
| 2.3 | Pathogenesis: host factors/histo-pathology |
| 2.4 | Diagnosis |
| 2.5 | Treatment |
| 2.6 | H. pylori-associated malignancies |
| 3 | INTESTINAL |
| 3.1 | Enterocyte biology/pathology and nutrient/water transport/electrolyte transport |
| 3.2 | Coeliac disease/malabsorption syndromes and food enteropathies |
| 4 | IBD |
| 4.1 | Basic/pathogenesis/pathology |
| 4.2 | Aetiology/epidemiology |
| 4.3 | Genetics |
| 4.4 | Diagnosis and monitoring |
| 4.5 | Treatment-medical |
| 4.6 | Treatment-surgical |
| 5 | COLONIC AND ANORECTAL DISORDERS |
| 5.1 | Malignant disease-epidemiology |
| 5.2 | Malignant disease, pathogenesis |
| 5.3 | Malignant disease, diagnosis/histopathology |
| 5.4 | Malignant disease, management |
| 5.5 | Other colonic and anorectal disorders |
| 6 | LIVER |
| 6.1 | Molecular biology, inflammation and fibrosis |
| 6.2 | Regeneration, stem cells and nutrition |
| 6.3 | Metabolic/genetic disorders |
| 6.4 | Hepatotoxicity/alcohol |
| 6.5 | Cirrhosis and complications: basic aspects |
| 6.6 | Cirrhosis and complications: clinical aspects |
| 6.7 | Viral hepatitis: basic aspects |
| 6.8 | Viral hepatitis B: clinical aspects |
| 6.9 | Viral hepatitis C: clinical aspects |
| 6.10 | Immunology, autoimmune liver disease |
| 6.11 | Acute liver failure, transplantation/surgery |
| 6.12 | Imaging, radiology (incl. interventional radiology) |
| 7 | BILIARY |
| 7.1 | Bile acids, transport, cholestasis |
| 7.2 | Gallstones |
| 7.3 | Hepato-biliary tumours |
| 8 | PANCREAS |
| 8.1 | Cell biology/secretion/enzymology/physiology |
| 8.2 | Pancreatitis, experimental |
| 8.3 | Pancreatitis, acute |
| 8.4 | Pancreatitis, chronic (including hereditary disorders) |
| 8.5 | Pancreatic cancer |
| 8.6 | Endocrine tumours of the pancreas |
| 9 | NUTRITION |
| 9.1 | Obesity |
| 9.2 | Nutrients and gut function |
| 9.3 | Enteral and parenteral nutrition |
| 10 | PAEDIATRIC GASTROENTEROLOGY AND HEPATOLOGY |
| 11 | SURGERY |
| 11.1 | Oesophagus / stomach / duodenum |
| 11.2 | Small bowel / colorectal and anal |
| 11.3 | Hepatobiliary / pancreas / spleen |
| 11.4 | Postoperative complications |
| 11.5 | Laparoscopic techniques |
| 12 | ONCOLOGY |
| 12.1 | Proliferation, carcinogenesis |
| 12.2 | Molecular biology/genetics/pathology |
| 12.3 | Clinical: epidemiology, screening and prevention |
| 12.4 | Diagnosis of malignant disease |
| 12.5 | Treatment of malignant disease |
| 13 | NERVE GUT AND MOTILITY |
| 13.1 | Transmitters/signals/receptors/enteric nervous system |
| 13.2 | Brain-gut and gut-brain axes, neuro-hormonal, neural-immune and visceral sensitivity |
| 13.3 | Upper GI motility |
| 13.4 | Lower GI motility |
| 13.5 | Functional gastrointestinal disorders (clinical, management) |
| 14 | IMMUNOLOGY/MICROBIOLOGY |
| 14.1 | Host defence mechanisms, immune reactions |
| 14.2 | Inflammation and inflammatory mechanisms |
| 14.3 | Gastrointestinal infections |
| 15 | VASCULAR DISEASE |
| 16 | GASTROINTESTINAL BLEEDING |
| 17 | ENDOSCOPY AND IMAGING |
| 17.1 | Endoscopy, Upper GI |
| 17.2 | Endoscopy, Colon |
| 17.3 | Endoscopy, ERCP |
| 17.4 | Endosonography |
| 17.5 | Enteroscopy |
| 17.6 | Capsule Endoscopy |
| 17.7 | Cross Sectional Imaging |
| 18 | THERAPEUTIC ENDOSCOPY/INTERVENTIONAL RADIOLOGY |
| 18.1 | Biliary and pancreatic stenting |
| 18.2 | Enteral dilatation and stenting (oesophagus, stomach, duodenum, colon) |
| 18.3 | Interventional Radiology |